SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-18-024904
Filing Date
2018-09-20
Accepted
2018-09-20 16:16:30
Documents
2
Period of Report
2017-09-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6400
2 EX-24 DOCUMENT attachment1.htm EX-24 4621
  Complete submission text file 0000899243-18-024904.txt   12491
Mailing Address 500 TOTTEN POND ROAD WALTHAM MA 02451
Business Address 500 TOTTEN POND ROAD WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Issuer) CIK: 0001654151 (see all company filings)

IRS No.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DECIPHERA PHARMACEUTICALS, LLC 500 TOTTEN POND ROAD WALTHAM MA 02451
Business Address
Morl Christopher John (Reporting) CIK: 0001716821 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38219 | Film No.: 181079610